Jonathan Goodman

Jonathan Ross Goodman was the founder of Paladin Labs, Inc., founded in 1983, where the titles held included Chairman, President & Chief Executive Officer from 1983 to 2014.
Mr. Goodman is the founder of Knight Therapeutics, Inc., founded in 2013, holding the title of Executive Chairman since 2021.
Current jobs include Director at Medison Biotech 1995 Ltd., Director at POINT Biopharma Corp., Director at POINT Biopharma, Inc. since 2020, Member of the New York State Bar Association, Member of the Massachusetts Bar Association, and Advisor at Maverix Private Equity.
Former jobs include Chairman at Isotechnika, Inc., Chairman at Isotechnika Pharma, Inc. from 2009 to 2010, Honorary Chairman at The Ride To Conquer Cancer, Director at Labopharm, Inc., Director at Medicago, Inc. from 2006 to 2011, Director at Kyowa Kirin International Plc, Director at NeurAxon, Inc., Director at Medimetriks Pharmaceuticals, Inc., Director at The Pelican, Inc., Independent Director at Antibe Therapeutics, Inc. from 2013 to 2015, Director at Profound Medical Corp., Lead Independent Director at POINT Biopharma Global, Inc. from 2021 to 2023, Principal at Procter & Gamble Co., Consultant at Bain & Co., Inc., and Vice President-Business Development at Pharmascience, Inc. Education includes undergraduate and graduate degrees from McGill University, an MBA from McGill University conferred in 1994, and an undergraduate degree from the London School of Economics & Political Science.